Objectives. Mitochondrial DNA (mtDNA) contains sequestered damage-associated molecular patterns that might be involved in osteoimmunological pathogenesis of RA. Here, we aimed to investigate the cellular source of mtDNA and its role in RANK ligand (RANKL) expression by RA SF neutrophils.
Introduction
As a result of their bacterial ancestry, mitochondria contain sequestered damage-associated molecular patterns (DAMPs) that can trigger innate immune responses during pathological insults, including cell stress [1] . This mitochondrial oxidative stress can then induce, trigger or activate innate immune responses [2] , including NOD like receptors family pyrin domain containing 3 (NLRP3) inflammasome activation or engagement of Toll-like receptors (TLRs) through the release of mitochondrial DNA (mtDNA) [3, 4] . Previous research has demonstrated that injection of purified mtDNA, but not nuclear DNA, into the joints of mice induces destructive arthritis [5] , suggesting a possible role in the pathogenesis of RA. Osteoclasts play a pivotal role in the development and progression of bone loss in RA. The RANK ligand (RANKL) is the key cytokine driving bone destruction by osteoclast activation. The cellular source of RANKL remains unclear [6] , among the cells residing in the joint neutrophils have been shown to both activate osteoclastogenesis and strongly express RANKL [7, 8] .
We examined the levels of extracellular mtDNA in plasma and SF from patients with RA or OA and from control subjects. We also investigated the potential cellular source of mtDNA and the impact of mtDNA release on RANKL expression by neutrophils. Our results demonstrate that RA neutrophils exhibit an oxidative stress gene expression signature, which could lead to release of mtDNA and a subsequent increase in RANKL expression, highlighting the importance of osteoimmunology in RA pathogenesis.
Methods

Subjects and samples
All studies were performed after obtaining approval from the ethics committee, Comite de protection des personnes Sud-Ouest et Outre Mer III, and informed consent from the subjects in the Rheumatology Department of Bordeaux Hospital, between July 2012 and May 2014. We collected SF samples from RA and OA patients undergoing evaluation or therapeutic knee puncture, and plasma samples from RA patients and volunteer healthy controls. The diagnosis of RA and OA was based on the criteria of the ACR. Subject characteristics are shown in supplementary Table S1 , available at Rheumatology Online.
Isolation of neutrophils
Neutrophils from SF and plasma samples were isolated as described by Kuhns et al. [9] . We obtained a pellet of neutrophils with 95% purity as assessed by Giemsa staining under optical microscopy.
Real-time PCR
After collection, SF and plasma samples were immediately centrifuged at 2500g for 15 min after collection, and the supernatants were purified according to the manufacturer's instructions using a NucleoSpin Tissue kit (Macherey Nagel, Dü ren, Germany). Isolated neutrophils from these samples were also purified as described above. DNA samples were analysed by quantitative realtime (RT)-PCR with the human mtDNA-specific primers mtF3212 and mtR3319 and iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA). Results were analysed with Bio-Rad CFX Manager software using a preestablished range. For intracellular mtDNA quantification, results were expressed as a ratio of the mitochondrial tRNA for leucine (UUR) mtDNA to 18S nuclear DNA. For more details, see supplementary Data, RT-PCR analysis section, available at Rheumatology Online. mtDNA isolation mtDNA was isolated from JRT3 cells using the ab65321 mitochondrial DNA isolation kit (Abcam, Cambridge, UK) according to the manufacturer's instructions. The quantity and purity of nucleic acids were then determined using a NanoDrop spectrophotometer.
Culture of neutrophils and flow cytometry analysis
The neutrophils were cultured for 18 h in 24-well plates (10 6 cells/well) in RPMI1640 supplemented with 8% fetal calf serum and GM-CSF (50 ng/ml). Cells were untreated or subjected to the following conditions: lipopolysaccharide (100 ng/ml), CpG-B (10 mg/ml), purified mtDNA or purified mtDNA that had been pretreated with DNase I. The concentrations of purified mtDNA were chosen based on concentrations found in highly active RA SF. After centrifugation, cells were labelled with 4 0 ,6-diamidino-2-phenylindole (to identify cells with intact membranes), antiCD66b and anti-RANKL. Data were collected using a BD FACSCanto II instrument and analysed using FlowJo software. Other methods (proteomics and network analysis), information on manufacturers and any associated references and statistical analysis section are detailed in the supplementary Data, available at Rheumatology Online.
Results
SF neutrophils from RA patients display a gene expression signature of oxidative stress
In addition to facilitating antibacterial and antiviral immunity, there is increasing evidence to suggest that mtDNA contributes to inflammatory diseases following cellular damage and stress [10] . We hypothesized that mitochondrial oxidative stress might occur in infiltrating neutrophils during RA to generate DAMPs. To address this, we performed unbiased quantitative proteomic analysis of purified neutrophils isolated from SF vs blood from RA patients. We identified 41 proteins, among which 23 were significantly upregulated based on label-free quantitative analysis, ranging from a 2.15-fold increase {Superoxide dismutase [Mn] , mitochondrial (Fragment) OS = Homo sapiens GN = SOD2; analysis of variance P = 1.65.10 À2 } up to 91.92-fold [Ig kappa chain VIV region (Fragment) OS = Homo sapiens GN = IGKV4-1; analysis of variance P = 2.13.10 À2 ]. We then submitted these 23 genes to pathway enrichment analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. The six most significantly enriched pathways were composed of immune-associated Gene Ontologies including acute inflammatory response (P = 2.10 À7 ; four genes) and immune response (P = 3.17.10 À6 ; eight genes; Fig. 1A ). We next searched for metabolic and reactive oxygen species-associated genes and observed that the most significant Gene Ontologies related to metabolism were linked to regulation of oxidative stress (Fig. 1B) . Using the same proteomic approach, we also compared supernatants of SF, free of any cells, from RA and OA patients and showed that only RA SF was characterized by a strong immune signature linked to the regulation of oxidative www.rheumatology.oxfordjournals.org stress (Fig. 1CE) . Collectively, unbiased proteomic analysis revealed a gene expression signature of oxidative stress specific only to SF neutrophils from RA patients. Therefore, given that mtDNA has been implicated in several inflammatory conditions [1, 1113] , we hypothesized that the observed oxidative environment in RA might promote the generation of DAMPs including mtDNA.
SF from RA patients contains high levels of extracellular mtDNA
The presence of mtDNA in RA SF has already been reported [14] . However, it remains unknown whether the intra-articular release of mtDNA is associated with RAinduced inflammatory conditions. It is possible that this release of pathogenic mtDNA might originate from infiltrating neutrophils displaying a gene expression signature of oxidative stress as shown above. We therefore used quantitative RT-PCR to determine the copy number of extracellular mtDNA in 27 RA and 12 OA SF available frozen samples ( Fig. 2A) , as well as in plasma from 40 RA patients and 15 healthy donors (supplementary Fig. S1A , available at Rheumatology Online). We observed that mtDNA copy number was significantly higher in SF from RA patients compared with OA patients (P = 0.0007) and to a lesser extent in RA plasma compared with controls (P = 0.0237).
In order to gain a better understanding of the influence of disease activity on mtDNA release, we looked at SF mtDNA copy number stratified on the DAS28-CRP (plasma CRP) scale. We observed that SF from patients with a DAS28-CRP score 55.1 contains a significantly higher copy number of mtDNA compared with patients scoring lower according to the DAS28-CRP scale (P = 0.023) or to OA patients (P = 0.0003; Fig. 2B ). Of note, mtDNA copy number in SF from RA patients was positively correlated with CRP concentrations (r = 0.8239, P < 0.0001; Fig. 2C ). Thus, RA-induced inflammatory conditions are associated with the presence of increased mtDNA in joints.
SF-derived neutrophils are a potential source of pathogenic mtDNA that promotes RANKL expression As neutrophils exhibit an oxidative stress gene expression signature and are the predominant cell type found in SF from RA patients (80%), we hypothesized that they could be one of the main sources of extracellular mtDNA. The number of neutrophils in SF from RA patients was positively correlated with the amount of extracellular mtDNA Values represent median/interquartile range (*P < 0.05, **P < 0.001 and ***P < 0.0001).
www.rheumatology.oxfordjournals.org not different between RA patients and controls, whereas the mtDNA:18S DNA ratio was significantly lower in SF neutrophils compared with blood neutrophils (P = 0.0188; Fig. 2D ). We then prospectively determined the mtDNA:18S DNA ratio from blood and SF neutrophils in seven RA patients. We found that the mtDNA:18S DNA ratio was significantly higher in blood neutrophils compared with SF neutrophils (P = 0.0156; Fig. 2E ). Taken together, these data suggest that neutrophils from RA patients could release mtDNA in SF.
SF-derived neutrophils from RA patients strongly express RANKL and activate osteoclastogenesis, thus contributing to joint destruction; however, the mechanisms responsible for RANKL overexpression by neutrophils are not well known. To address whether mtDNA could be responsible for upregulation of RANKL membrane expression by neutrophils, we treated purified healthy neutrophils in vitro with either CpG-B (TLR9 ligand), lipopolysaccharide (TLR4 ligand), purified mtDNA or purified mtDNA pretreated with DNase I. Purified mtDNA induced RANKL expression by neutrophils to the same extent as TLR4 and TLR9 agonists, whereas pretreatment of mtDNA by DNase I completely abrogated this effect (Fig. 2F ). These data suggest that neutrophils from RA patients release mtDNA, which could act in an autocrine loop to upregulate RANKL expression.
Discussion
Recent research has demonstrated that mtDNA activates several innate immune pathways involving TLR9, NLRP3 and STING, which results in effector responses [1, 3, 11] . In general, mtDNA released after cellular damage and stress plays an important role in the development of several inflammatory conditions, including sterile systemic inflammatory response syndrome, acute liver failure, atherosclerosis and heart disease [1, 12, 13, 15] . In the context of systemic autoimmunity, Lood et al. [16] recently demonstrated that stimulation of neutrophils by immune complexes containing nuclear components produced reactive oxygen species and released oxidized mtDNA that contributed to lupus-like disease.
Although homeostatic mechanisms have evolved to protect the genome from damage by oxidative stress, certain conditions will stimulate the release of genomic and mtDNA, which is particularly vulnerable to oxidant damage. Previous studies have demonstrated that oxidative stress, characterized by high levels of reactive oxygen species in SF, is involved in RA pathogenesis [17] . In the study presented here, proteomic analysis revealed that infiltrating SF neutrophils in RA exhibit an oxidative stress gene expression profile, demonstrating an association between the increased presence of mtDNA in RA joints and the oxidative stress signature.
In addition, we demonstrate that mtDNA induces RANKL expression by neutrophils in RA to a similar extent as TLR4 and TLR9 ligands. This suggests that mtDNA might act as a DAMP, driving bone erosion, in line with a published study demonstrating that surface expression of RANKL on TLR4-stimulated human neutrophils results in bone resorption by osteoclasts [7] . Although the presence of mtDNA in RA SF has been reported, the cellular source of extracellular mtDNA that might activate resident cells is not known. Here, we suggest that neutrophils are the main source of SF mtDNA, whereas the contribution of mtDNA from other cell types is negligible. Moreover, mtDNA levels are significantly enhanced compared with OA SF. Interestingly, for the first time, we report higher intra-articular mtDNA levels in the RA patients with high disease activity and correlate this with systemic inflammation, as assessed by CRP concentrations.
In conclusion, our work suggests that RA neutrophils display a gene expression signature of oxidative stress that leads to mtDNA release that could promote RANKL expression, resulting in enhanced progression of damage to the joints. These observations contribute to our understanding of the role of neutrophils in RA.
